United Kingdom

Indication: For the treatment and prophylaxis of mania, manic-depressive illness, and recurrent depression, and the treatment of aggressive or self-mutilating behaviour.
Brand name: Camcolit (Norgine), Liskonum (GSK), Priadel (Sanofi-Synthelabo).
Regulatory status: Approved.
Launch date: Not applicable.